4//SEC Filing
Goldberg Andrew D. 4
Accession 0001628280-22-018342
CIK 0001819790other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 12:21 PM ET
Size
7.9 KB
Accession
0001628280-22-018342
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-16+7,000→ 7,000 totalExercise: $12.89Exp: 2032-06-15→ Common Stock (7,000 underlying) - Award
Restricted Stock Units
2022-06-16+2,000→ 2,000 total→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827722
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 12:21 PM ET
- Size
- 7.9 KB